| Identification | Back Directory | [Name]
Naroparcil | [CAS]
120819-70-7 | [Synonyms]
Naroparcil Unii-238m5105oy Naroparcil [inn] Benzonitrile, 4-[4-[(5-thio-β-D-xylopyranosyl)thio]benzoyl]- | [Molecular Formula]
C19H17NO4S2 | [MDL Number]
MFCD00866788 | [MOL File]
120819-70-7.mol | [Molecular Weight]
387.47 |
| Hazard Information | Back Directory | [Uses]
Naroparcil is an orally active antithrombotic agent. Naroparcil exhibits antithrombotic effects in rabbit Wessler stasis model with EC50s of 21.9 mg/kg and 36.0 mg/kg after respectively intravenous injection and oral administration[1]. | [References]
[1] Millet J, et al. The venous antithrombotic profile of naroparcil in the rabbit. Thromb Haemost. 1994 Dec;72(6):874-9. PMID:7740457 |
|
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|